Key result
Combined treatment with siRNA, interferon alpha, and ribavirin eliminated BVDV from porcine LFBKαVβ6 cells without altering their high susceptibility to foot-and-mouth disease virus.
Why the study?
Porcine LFBKαVβ6 cells used for FMDV diagnostics showed contamination with bovine viral diarrhea virus, which could interfere with diagnostic tests and prevent vaccine production.
Answers are grounded in this paper and cite their sources.
A three-prong treatment successfully eliminated BVDV contamination from porcine LFBKαVβ6 cells without altering their utility for FMDV diagnostics and propagation.
Porcine LFBKαVβ6 cells have been successfully used for diagnostics and propagation of all FMDV serotypes/subtypes. Unfortunately, after initial characterization, these cells showed contamination with bovine viral diarrhea virus (BVDV), a non-cytopathic adventitious agent. Persistent infection with BVDV could interfere with diagnostic tests and, also prevent consideration for other uses, i.e., vaccine production. In this study, we developed a three-prong methodology to completely remove BVDV from LFBKαVβ6 cells. Combined treatment with siRNA against BVDV NS5A, porcine interferon alpha and ribavirin resulted in the elimination of BVDV, as determined by immunohistochemistry analysis, quantitative RT-PCR and RNA sequencing. Importantly, elimination of BVDV from LFBKαVβ6 did not affect FMDV growth and plaque phenotype from different serotypes isolated and propagated in the clean cell line, newly named MGPK αVβ6-C5. Additionally, isolation of FMDV from field oro-pharyngeal samples, was successful at the same sensitivity as in BVDV-contaminated LFBKαVβ6 cells. Our results identified a direct method to efficiently eliminate BVDV from porcine cells without altering FMDV permissiveness, diagnostic value, or potential for use in vaccine production. Furthermore, these cells may provide an improved platform for diagnostics and propagation of other viruses of interest in the veterinary field and the virology community at large.
No takes yet. Share an insight, caveat, or question.
LaRocco et al. (2021) studied this question. Combined treatment with siRNA, interferon alpha, and ribavirin eliminated BVDV from porcine LFBKαVβ6 cells without altering their high susceptibility to foot-and-mouth disease virus.
Synapse has enriched 10 related papers. Consider them for comparative context: